Pathogen-inactivated red blood cell compositions
US9713627B2 · kind B2 · utility
12Cited by
39References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2014 |
| Grant date | Jul 25, 2017 |
| Priority date | — |
| Expiry date | Nov 6, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2/0082
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pathogen-inactivated red blood cell compositions suitable for infusion into a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.